Welcome to our dedicated page for Philip Morris SEC filings (Ticker: PM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Philip Morris International Inc. (PM) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, including current reports on Form 8‑K, annual reports on Form 10‑K and quarterly reports on Form 10‑Q. As an NYSE‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Securities Exchange Act of 1934, PMI files a broad range of documents that shed light on its operations, financing activities and risk profile.
Form 8‑K filings for PM frequently report material events such as dividend declarations, earnings releases, financing transactions and organizational changes. Recent 8‑Ks describe regular quarterly dividends, the issuance of floating rate and fixed-rate notes with maturities extending into the 2030s, the establishment and extension of revolving credit facilities, and the planned redemption of outstanding notes. Other 8‑Ks cover PMI’s new organizational model, including the creation of business units focused on International, U.S. and wellness activities, and changes in executive officer designations.
PMI’s periodic reports on Form 10‑K and Form 10‑Q, referenced in its news releases and 8‑K filings, include detailed discussions of business risks, segment information and financial results. The company points readers to these filings for comprehensive risk factor disclosures, including taxation, regulation, litigation, competition, currency and supply chain considerations, as well as risks tied to the success of its smoke-free products and acquisitions.
Investors can also use this page to review filings related to PMI’s debt securities, including descriptions of note issuances, covenants, maturity profiles and redemption terms. Credit agreements and amendments, filed as exhibits to 8‑Ks, outline the structure of PMI’s revolving credit facilities and related events of default. For those monitoring capital structure and liquidity, these documents provide insight into how PMI funds its operations, refinances existing obligations and manages access to bank and bond markets.
Stock Titan enhances these filings with AI-powered summaries that explain key terms, highlight significant changes and help users navigate complex documents such as 10‑Ks, 10‑Qs, credit agreements and note indentures. Real-time updates from the SEC’s EDGAR system ensure that new PM filings, including Form 4 insider transaction reports when available, appear promptly, allowing users to track executive and director dealings alongside broader corporate disclosures.
Philip Morris International reports proposed sales of vested equity awards under a Form 144. The notice lists multiple vested restricted and performance awards tied to grant dates of 02/15/2023 and 02/21/2024, with examples including 3,227 and 9,436 shares, and a broker listed as UBS Financial Services Inc.
Philip Morris International reports an intended sale of 4,000 shares of Common Stock. The form lists the broker UBS Financial Services Inc and shows settlement/transaction activity on 02/18/2026 and 02/19/2026.
The entries identify two award types that vested on 02/18/2026: a Vested Restricted Award and a Vested Performance Award, with sale movement recorded as Wire through UBS on 02/19/2026.
Philip Morris International Inc. furnished an investor presentation from the CAGNY conference, outlining its strategy to become predominantly smoke-free and its financial targets. Smoke-free products generated $16,854 million of 2025 net revenues, or 41.5% of the total $40,648 million, and contributed an increasing share of gross profit.
The company reported 2025 adjusted net revenues up 7.9% from 2024 on an organic basis and strong operating income growth, with 2020‑2025 adjusted operating income rising from $11,771 million to $16,428 million. Adjusted diluted EPS reached $7.54 in 2025, with currency-neutral growth of 14.2%.
For 2026‑2028, Philip Morris targets a 6‑8% organic net revenue CAGR, 8‑10% operating income organic CAGR, and 9‑11% currency-neutral adjusted diluted EPS CAGR, supported by high single- to low-teens volume growth in smoke-free products. The company expects about $45 billion of operating cash flow over 2026‑2028 and emphasizes ongoing dividend growth and deleveraging toward roughly 2.0x net debt to adjusted EBITDA.
Philip Morris International Inc. is presenting at the 2026 Consumer Analyst Group of New York Conference, where its CEO and CFO will discuss strategy, smoke-free products and shareholder returns, including 2026–2028 growth targets.
PMI reaffirmed its 2026 full-year reported diluted EPS forecast of $7.87 to $8.02. The company expects adjusted diluted EPS of $8.38 to $8.53, a projected increase of 11.1% to 13.1% versus $7.54 in 2025. Excluding a favorable currency impact of $0.27 per share, this implies adjusted diluted EPS of $8.11 to $8.26, or 7.5% to 9.5% growth.
PMI highlights that smoke-free products accounted for 41.5% of its full-year 2025 net revenues and estimates over 43 million adult consumers were using its smoke-free products as of December 31, 2025. The release also outlines extensive risk factors that could cause actual results to differ from these projections.
Philip Morris International Group CEO Jacek Olczak reported two equity awards. On February 5, 2026, he acquired 137,579 shares of common stock at $0, earned after the board certified achievement of the third-year performance goal for performance stock units granted on February 9, 2023. These PSUs vest on February 18, 2026.
On February 6, 2026, he received 33,460 restricted share units under the 2022 Performance Incentive Plan at a reference price of $172.93, based on the 20-day average closing price before that date. These RSUs will vest on February 21, 2029. Following these transactions, he beneficially owned 718,465 common shares, including 179,780 restricted share units, all held directly.
Philip Morris International CEO PMI U.S. Stacey Kennedy reported two equity awards in company common stock. On February 5, 2026, she acquired 11,780 shares at $0, earned from performance stock units granted in 2023 after the board certified achievement of a three-year performance goal; these PSUs vest on February 18, 2026. On February 6, 2026, she received 4,430 restricted share units under the 2022 Performance Incentive Plan at a reference price of $172.93, which will vest on February 21, 2029. Following these transactions, she directly beneficially owned 63,975 shares of common stock, including 22,600 restricted share units.
Philip Morris International director and chairman Andre Calantzopoulos reported an equity award of 40,052 shares of common stock on February 5, 2026. These shares were earned after the board certified achievement of the year-three performance goal for Performance Stock Units granted on February 9, 2023, which vest on February 18, 2026. After this award, he directly holds 602,403 shares of common stock. An additional 398,412 shares are reported as indirectly owned by his spouse, and he disclaims beneficial ownership of those spouse-held shares.
Philip Morris International Inc. Group Controller Reginaldo Dobrowolski reported multiple stock awards. On February 5, 2026, he acquired 3,838 shares of common stock at $0, earned from performance stock units tied to a three-year performance goal.
On February 6, 2026, he received 1,960 restricted share units valued at an average reference price of $172.93 per share under the 2022 Performance Incentive Plan. On the same date, 740 shares were acquired indirectly through his spouse at the same reported price, bringing his holdings to 26,392 direct and 8,294 indirect shares.